News
Alzheimer’s disease (AD) is a complex and multifactorial neurodegenerative disease, which is currently diagnosed via clinical symptoms and nonspecific biomarkers (such as Aβ1–42, t-Tau, and p-Tau) ...
Early detection of the stage of mild cognitive impairment (MCI) is very important for early diagnosis of dementia and slowing down the progression of Alzheimer's disease. Atrophy values obtained by ...
By Siddhi Mahatole and Puyaan Singh (Reuters) -INmune Bio said on Monday its experimental Alzheimer's drug failed to improve ...
2d
HealthDay on MSNTriglyceride-Glucose Index May Predict Faster Cognitive Decline in Early Phases of Alzheimer DiseaseFor patients with mild cognitive impairment (MCI) associated with Alzheimer disease (AD), those in the highest tertile of the ...
Cognitive impairment in cardiac patients may interfere with disease management. This review describes studies examining specific cognitive impairments in cardiac patients and studies that investigate ...
A new study suggests eating more antioxidant-rich foods may lower cognitive decline risk by 80%. Participants who ate the ...
This new study takes a deeper look at how some of those modifiable risks actually affect Alzheimer’s disease at a biological ...
Saffron shows promise as a natural treatment for depression and cognitive decline, performing as well as standard drugs in ...
Researchers from the US, UK, and Spain tracked more than 10,000 people over the age of 50. Higher levels of well-being may ...
Education, body mass index (BMI), and hypertension play a role in the spread of tau tangles, a hallmark of Alzheimer's ...
Abstract. Non-pharmacological cognitive interventions in mild cognitive impairment have demonstrated promising results in preventing or delaying cognitive impairment and functional disability.
We were surprised to see the effect only in the Alzheimer’s spectrum and not in other neurodegenerative diseases." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results